Pancreatic sarcoidosis: MRI features.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 15503350)

Published in J Magn Reson Imaging on November 01, 2004

Authors

Ronaldo H Baroni1, Ivan Pedrosa, Ekaterini Tavernaraki, Jeffrey Goldsmith, Neil M Rofsky

Author Affiliations

1: Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.

Articles citing this

Abdominal sarcoidosis: cross-sectional imaging findings. Diagn Interv Radiol (2015) 0.92

Sarcoidosis of the pancreas mimicking adenocarcinoma. BMJ Case Rep (2013) 0.91

A Rare Presentation of Sarcoidosis as a Pancreatic Head Mass. Case Rep Pulmonol (2017) 0.75

Articles by these authors

MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology (2004) 3.59

Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol (2010) 2.59

Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology (2012) 2.18

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. Radiology (2009) 2.08

The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol (2011) 1.96

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. Radiology (2007) 1.67

Toward single breath-hold whole-heart coverage coronary MRA using highly accelerated parallel imaging with a 32-channel MR system. Magn Reson Med (2006) 1.61

Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience. Int J Radiat Oncol Biol Phys (2007) 1.58

MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics (2008) 1.54

Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson (2006) 1.54

Highly parallel volumetric imaging with a 32-element RF coil array. Magn Reson Med (2004) 1.53

Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: initial experience. Eur Radiol (2011) 1.44

Double inversion black-blood fast spin-echo imaging of the human heart: a comparison between 1.5T and 3.0T. J Magn Reson Imaging (2003) 1.44

Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma. Eur Urol (2011) 1.43

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? Radiology (2009) 1.42

Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery. J Magn Reson Imaging (2012) 1.38

Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer. Comput Med Imaging Graph (2011) 1.28

Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcoma. PLoS One (2011) 1.24

Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res (2008) 1.20

MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol (2004) 1.17

Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol (2006) 1.15

MR classification of renal masses with pathologic correlation. Eur Radiol (2007) 1.14

Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int (2011) 1.13

Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examination. AJNR Am J Neuroradiol (2002) 1.12

Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology (2010) 1.12

Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI. Eur Radiol (2012) 1.11

3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). Acad Radiol (2004) 1.09

Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08

Time-resolved vessel-selective digital subtraction MR angiography of the cerebral vasculature with arterial spin labeling. Radiology (2010) 1.08

Visualization and quantification of renal R2* changes during water diuresis. J Magn Reson Imaging (2003) 1.07

Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome. Eur J Cancer (2012) 1.07

A method for the determination of proximal pulmonary vein size using contrast-enhanced magnetic resonance angiography. J Cardiovasc Magn Reson (2004) 1.06

Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1). Acad Radiol (2005) 1.06

Pregnant patients suspected of having acute appendicitis: effect of MR imaging on negative laparotomy rate and appendiceal perforation rate. Radiology (2009) 1.06

Discordance about the use of the term minimal fat angiomyolipoma. Radiology (2013) 1.06

Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med (2009) 1.05

Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magn Reson Med (2003) 1.05

3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension. Magn Reson Med (2007) 1.04

Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer (2009) 1.04

Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings. Radiology (2012) 1.04

Nephrogenic systemic fibrosis: a chemical perspective. Radiology (2008) 1.03

Magnetic resonance imaging findings in solitary fibrous tumor of the kidney. J Comput Assist Tomogr (2005) 1.02

Body MR imaging at 3.0 T: understanding the opportunities and challenges. Radiographics (2007) 1.02

T(2)-weighted 3D fast spin echo imaging with water-fat separation in a single acquisition. J Magn Reson Imaging (2010) 1.01

The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach. Cancer Biomark (2008) 1.00

Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol (2013) 0.97

MR imaging evaluation of acute appendicitis in pregnancy. Radiology (2006) 0.97

Quantitative analysis of the velocity and synchronicity of diaphragmatic motion: dynamic MRI in different postures. Magn Reson Imaging (2006) 0.96

Massive intraperitoneal bleeding due to hemorrhagic cholecystitis and gallbladder rupture: CT findings. Abdom Imaging (2011) 0.96

Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors. J Magn Reson Imaging (2014) 0.96

Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer. Invest Radiol (2010) 0.95

Shortening MR image acquisition time for volumetric interpolated breath-hold examination with a recently developed parallel imaging reconstruction technique: clinical feasibility. Radiology (2003) 0.94

MR imaging of acute right lower quadrant pain in pregnant and nonpregnant patients. Radiographics (2007) 0.94

Contrast-enhanced whole-heart coronary MRI with bolus infusion of gadobenate dimeglumine at 1.5 T. Magn Reson Med (2010) 0.94

Rapid volumetric MRI using parallel imaging with order-of-magnitude accelerations and a 32-element RF coil array: feasibility and implications. Acad Radiol (2005) 0.92

Part I: preparing first-year radiology residents and assessing their readiness for on-call responsibilities. Acad Radiol (2006) 0.92

Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months. J Clin Oncol (2013) 0.90

Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer (2009) 0.90

Preparing first-year radiology residents and assessing their readiness for on-call responsibilities: results over 5 years. AJR Am J Roentgenol (2009) 0.90

Quality initiatives: imaging pregnant patients with suspected pulmonary embolism: what the radiologist needs to know. Radiographics (2009) 0.90

Multi-detector row computed tomography and blunt chest trauma. Eur J Radiol (2007) 0.89

Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease. Eur J Cardiothorac Surg (2004) 0.89

Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. AJR Am J Roentgenol (2011) 0.89

MR Imaging-Transrectal US Fusion for Targeted Prostate Biopsies: Implications for Diagnosis and Clinical Management. Radiographics (2015) 0.89

Noncardiac pathology on clinical cardiac magnetic resonance imaging. JACC Cardiovasc Imaging (2009) 0.89

Dynamic subtraction MR imaging of the liver: advantages and pitfalls. AJR Am J Roentgenol (2003) 0.89

An unusual variant of anomalous pancreaticobiliary junction in a patient with pancreas divisum diagnosed with secretin-magnetic resonance cholangiopancreatography. Pancreas (2010) 0.89

Brain MR imaging at ultra-low radiofrequency power. Radiology (2011) 0.88

Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer. Magn Reson Imaging Clin N Am (2009) 0.88

Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 0.87

Body MRI using IDEAL. AJR Am J Roentgenol (2008) 0.87

MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging (2014) 0.86

Accurate prostate volume estimation using multifeature active shape models on T2-weighted MRI. Acad Radiol (2011) 0.86

Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis. Am J Surg Pathol (2008) 0.86

MR techniques for renal imaging. Radiol Clin North Am (2003) 0.86

Short breath-hold, volumetric coronary MR angiography employing steady-state free precession in conjunction with parallel imaging. Magn Reson Med (2005) 0.86

Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology (2014) 0.85

Ischemic colitis in marathon runners: a case-based review. J Emerg Med (2006) 0.85

Noncontrast SSFP pulmonary vein magnetic resonance angiography: impact of off-resonance and flow. J Magn Reson Imaging (2010) 0.85